
Sign up to save your podcasts
Or


Plus: Cidara Therapeutics stock doubles after a bid from Merck. And Under Armour shares fall after dropping a deal with Stephen Curry. Katherine Sullivan hosts.
Sign up for the WSJ's free What's News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
644644 ratings
Plus: Cidara Therapeutics stock doubles after a bid from Merck. And Under Armour shares fall after dropping a deal with Stephen Curry. Katherine Sullivan hosts.
Sign up for the WSJ's free What's News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,840 Listeners

1,717 Listeners

4,358 Listeners

409 Listeners

432 Listeners

1,641 Listeners

1,451 Listeners

1,040 Listeners

183 Listeners

1,302 Listeners

6,086 Listeners

1,554 Listeners

208 Listeners

1,322 Listeners

607 Listeners

151 Listeners

73 Listeners

73 Listeners

147 Listeners